Assured Investment Management’s ResMed RMD Stock Holding History

Assured Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-30,601	Closed	-$3.48M	–	1328
2018 Q4	$3.48M	Sell	30,601 -49,570	-62%	-$5.31M	0.1%	264
2018 Q3	$9.25M	Buy	80,171 +39,319	+96%	+$4.31M	0.17%	113
2018 Q2	$4.23M	Buy	40,852 +4,372	+12%	+$442K	0.08%	282
2018 Q1	$3.59M	Buy	+36,480	New	+$3.45M	0.08%	273
2017 Q4	–	Sell	-10,931	Closed	-$841K	–	642
2017 Q3	$841K	Buy	+10,931	New	+$836K	0.02%	455
2017 Q2	–	Sell	-11,970	Closed	-$861K	–	693
2017 Q1	$861K	Buy	+11,970	New	+$827K	0.02%	333
2016 Q2	–	Sell	-5,068	Closed	-$293K	–	666
2016 Q1	$293K	Buy	+5,068	New	+$287K	0.01%	426

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assured Investment Management's RMD Position: Q1 2019 in Review

Assured Investment Management sold out of ResMed (RMD) in Q1 2019, closing a stake of 30,601 shares — an estimated $3.48M sold.

Assured Investment Management first reported a position in RMD in Q1 2016 and held it in 7 quarters. The position peaked at $9.25M in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

Assured Investment Management reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
Assured Investment Management sold 30,601 ResMed shares in Q1 2019, an estimated $3.48M.
Assured Investment Management first reported a position in ResMed in Q1 2016 and held it in 7 quarters.
Assured Investment Management's ResMed position peaked at $9.25M in Q3 2018.
477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.